Pharma Leaders
Refine Search
Latest Pharma Leaders News & Features
Pharmaceutical
With marketing expenses stretching into the tens or even hundreds of millions of dollars, launching a new product can be a huge challenge for small pharmaceutic 12 July 2019
Biotechnology
As industry majors prepare to make a splash at the upcoming annual meeting of the American Society of Clinical Oncology (ASCO), 2003-founded nanomedicine specia 24 May 2019
Pharmaceutical
The runaway success of Adcetris (brentuximab vedotin) has ensured the future of Seattle Genetics as antibody-drug conjugate specialist, but chief executive Clay 13 December 2018
Pharmaceutical
In the USA alone, more than 10% of adults or adolescents take antidepressants, and fully two-thirds of these people do not respond to first-line treatment, norm 26 November 2018
Biotechnology
As far as PARP inhibitors are concerned, AstraZeneca stole the show at the annual congress of ESMO this month, with the SOLO-1 trial of Lynparza (olaparib) show 9 November 2018
Pharmaceutical
While PARP blocker rivals AstraZeneca and Tesaro chase the prize of a first-line ovarian cancer indication, Clovis Oncology is highlighting what it sees as prom 19 October 2018
Pharmaceutical
With World Alzheimer’s Day fast approaching, drugmakers and patients around the world are raising awareness of the challenges faced, and the progress made, in c 20 September 2018
Biotechnology
UCB (Euronext: UCB) rose 1.3% on Thursday after it published financial results for the first half of 2018. The Belgian drugmaker, which specialises in immunolog 26 July 2018
Pharmaceutical
For several years, pharma analysts have predicted varying degrees of impact from nascent blockchain technologies. While some anticipate wholesale revolution, ot 23 July 2018
Biotechnology
When Seattle Genetics announced it had bought exclusive global rights to an an exciting new antibody-drug conjugate (ADC), sacituzumab govitecan (IMMU-132), sha 9 July 2018
Pharmaceutical
Pharma companies sometimes need to be aware of advances in wearable technology that threaten to take market share away from their medicines, but such devices ca 2 July 2018
Biotechnology
Despite an inexorable rise in the global population of type 2 diabetics, linked to changing lifestyle choices, markets for insulin are becoming ever more compet 30 May 2018
Biotechnology
Soaring obesity rates and the accompanying scourge of type II diabetes have done wonders for insulin kingpin Novo Nordisk’s bottom line over the last quarter-ce 23 May 2018
Pharmaceutical
Belén Garijo has been the CEO of the Healthcare business of German life sciences firm Merck KGaA since 2015. Speaking to The Pharma Letter, she discusses her co 17 May 2018
Pharmaceutical
The progress achieved in treating huge swathes of the world’s HIV-infected population in the last 20 to 30 years might give the impression of a therapy area whe 8 May 2018
Biotechnology
A newcomer on the biologics scene expressing a vision to become a global player is nothing new, but it is a bold ambition when coming from CinnaGen, an Iranian 30 April 2018
Biotechnology
Since the inception of the biopharmaceutical age in the 1980s, the share of the market held by large molecules has risen steadily to about a fifth, and growth i 23 April 2018
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze